HOUSTON, TX, September 30, 2010 (Press-News.org) Houston Janitorial Services has done it again. Based on the industry's first Tier One Safety system, Houston Janitorial has ramped up its service processes again. With focus on safety firmly established, janitorial service process training has taken place with service-level staff.
The safety program is called the Tier One Safety System. This system gives facility owners the assurance that the staff in their buildings have the highest regard for safe activity.
The Tier One Safety System has now been enhanced by adding the new Quality Cleaning Process for commercial real estate. Many of their Houston, Texas janitorial service clients, such as Cameron and Whataburger, now benefit from the new process.
The Quality Cleaning Process offers several benefits to clients:
1. Built-In cleaning inspections by service staff added to quality inspections
2. Job-specific cleaning
3. Healthy cleaning guidelines
4. Green cleaning guidelines for Houston area LEED buildings
Houston Janitorial Services CEO states:
"While exploring our service process chain, we found that we could formalize our cleaning processes in the same way our safety training had been formalized. The creation of the Quality Cleaning Process enables our clients to receive a written & branded process which can be used for all of our office building clients."
For more information, please visit www.houstonjanitorial.com.
Houston Janitorial Services provides the highest quality process-driven janitorial services throughout the greater Houston, Texas metro. With capabilities to service Katy, The Woodlands, Spring, Humble, Kingwood and Sugar Land. We specialize in commercial office buildings from 20,000 square feet to 1,000,000 square feet.
Houston Janitorial Services Creates World Class Training System
Houston Janitorial Services Company has saved numerous Houston companies hundreds of thousands of dollars in operations and maintenance costs by making sure its staff are the best-trained in the industry. The Tier One Safety System has a new tool.
2010-09-30
ELSE PRESS RELEASES FROM THIS DATE:
Find New Customers Announces Webinar Series on B2B Marketing and Demand Generation
2010-09-30
With sales quota achievement at an all-time low and the worst economic downturn in memory, Find New Customers, a B2B sales and marketing automation consultancy, announces a series of webinars with top B2B marketing thought leaders. The "B2B Demand Generation Thought Leadership Series" is designed to help B2B companies develop the strategies and tactics necessary to increase sales-ready leads and close more business. The lineup of B2B marketing experts will be announced in early October. More information about the webinar series can be found at http://www.FindNewCustomers.com/B2B-webinar.
Paige ...
Guide to Natural Eczema Treatments Hits the Market - From Eczema Free Forever TM
2010-09-30
Eczema Free Forever TM provides answers to practical, homemade and natural solutions, that the eczema suffering population in any part of the world can easily perform in the comfort of their home.
One in eight people suffer from eczema in the U.S. That's 15 million people. What causes eczema? Which eczema treatment works best? These are questions that the millions of people with the condition ask regularly.
There certainly is no shortage of medicines available on the market that lay claim to being the absolute best cure for eczema. The creams and oily goop that pass ...
Triple-negative breast cancers may have unique therapeutic target
2010-09-29
DENVER — Patients with triple-negative breast cancer, one of the hardest subtypes to treat, may have a unique biomarker that would enable them to receive more targeted therapy, according to data presented at the Fourth AACR International Conference on Molecular Diagnostics in Cancer Therapeutic Development.
Triple-negative breast cancers are breast cancers that have tested negative for estrogen receptors, progesterone receptors and HER2. Because of this biology, these cancers do not respond to endocrine therapies or trastuzumab.
"In other subsets of breast cancer, ...
Circulating tumor cells can provide 'real-time' information on patient's current disease state
2010-09-29
DENVER — Circulating tumor cells (CTCs) may be a promising alternative, noninvasive source of tumor materials for biomarker assessment, according to data presented at the Fourth AACR International Conference on Molecular Diagnostics in Cancer Therapeutic Development.
"The basic idea is that CTCs can provide real-time information about a patient's current disease state, acting as a 'liquid biopsy,'" said Siminder Kaur Atwal, Ph.D., senior research associate at Genentech. "They are much less invasive than tumor biopsies because they can be detected from a blood draw and ...
Biomarker panel identifies prostate cancer with 90 percent accuracy
2010-09-29
DENVER — Researchers in England say they have discovered a set of biomarkers that can distinguish prostate cancer from benign prostate disease and healthy tissue with 90 percent accuracy. This preliminary data, if validated in larger ongoing studies, could be developed into a serum protein test that reduces the number of unnecessary biopsies and identifies men who need treatment before symptoms begin.
The researchers, from Oxford Gene Technology (OGT) and its subsidiary, Sense Proteomic, Ltd., presented their findings at the Fourth AACR International Conference on Molecular ...
New biomarkers discovered for pancreatic cancer and mesothelioma
2010-09-29
DENVER — Using a novel aptamer-based proteomics array technology, researchers and collaborators have identified biomarkers and protein signatures that are hallmarks of cancer at an early stage for two of the most aggressive and deadly forms of cancer — pancreatic and mesothelioma.
This technology would enable better clinical diagnosis at an earlier stage and may provide insight into new therapeutic targets, said Rachel Ostroff, Ph.D., clinical research director of Somalogic Inc.
"Currently these cancers are detected at an advanced stage, where the possibility of cure ...
African-Americans equally likely to benefit from erlotinib and other targeted lung cancer therapy
2010-09-29
DENVER — African-American patients with non-small cell lung cancer are just as likely to display an epidermal growth factor receptor (EGFR) mutation in tumors as Caucasians, which suggests they are as likely to benefit from targeted therapies such as erlotinib.
"This study has immediate implications for patient management. Patients with EGFR mutations have a much better prognosis and respond better to erlotinib than those who do not," said Ramsi Haddad, Ph.D., director of the Laboratory of Translational Oncogenomics at the Barbara Ann Karmanos Cancer Institute, and assistant ...
Novel biomarker may predict response to new VEGF receptor inhibitor
2010-09-29
DENVER — Researchers believe there may be a way to predict, based on individual tumors, those patients that are more likely to respond to the investigational new drug tivozanib.
This is possible, the researchers from AVEO Pharmaceuticals, Inc. said, because they have used a new way of creating animal tumor models that mimic tumor variation seen in human. Based on the results of these studies, they have found a single biomarker that may predict resistance to tivozanib, an oral, triple VEGF (vascular endothelial growth factor) receptor inhibitor.
Tivozanib is in an ...
Nanotechnology brings personalized therapy 1 step closer to reality
2010-09-29
DENVER — A novel technology can make nanoscale protein measurements, which scientists can use in clinical trials to learn how drugs work.
"We are making progress toward the goal of understanding how drugs work in different individuals," said Alice C. Fan, M.D., instructor in the division of oncology at Stanford University School of Medicine. "Using new technologies makes it possible to measure effects of therapeutic agents in tumor cells and different cell populations within our patients. Now that we can make these measurements, we are one step closer to being able to ...
Method to detect bladder cancer earlier is under development
2010-09-29
DENVER — Scientists may have discovered a way to diagnose bladder cancer at its earliest and, therefore, most treatable stages by measuring the presence or absence of microRNA using already available laboratory tests.
"Measuring expressions of microRNA in bodily fluid represents a very promising tool with widespread implications for screening," said Liana Adam, M.D., Ph.D., assistant professor in urology at The University of Texas MD Anderson Cancer Center.
Adam presented her findings at the Fourth AACR International Conference on Molecular Diagnostics in Cancer Therapeutic ...
LAST 30 PRESS RELEASES:
A tug-of-war explains a decades-old question about how bacteria swim
Strengthened immune defense against cancer
Engineering the development of the pancreas
The Journal of Nuclear Medicine ahead-of-print tip sheet: Jan. 9, 2026
Mount Sinai researchers help create largest immune cell atlas of bone marrow in multiple myeloma patients
Why it is so hard to get started on an unpleasant task: Scientists identify a “motivation brake”
Body composition changes after bariatric surgery or treatment with GLP-1 receptor agonists
Targeted regulation of abortion providers laws and pregnancies conceived through fertility treatment
Press registration is now open for the 2026 ACMG Annual Clinical Genetics Meeting
Understanding sex-based differences and the role of bone morphogenetic protein signaling in Alzheimer’s disease
Breakthrough in thin-film electrolytes pushes solid oxide fuel cells forward
Clues from the past reveal the West Antarctic Ice Sheet’s vulnerability to warming
Collaborative study uncovers unknown causes of blindness
Inflammatory immune cells predict survival, relapse in multiple myeloma
New test shows which antibiotics actually work
Most Alzheimer’s cases linked to variants in a single gene
Finding the genome's blind spot
The secret room a giant virus creates inside its host amoeba
World’s vast plant knowledge not being fully exploited to tackle biodiversity and climate challenges, warn researchers
New study explains the link between long-term diabetes and vascular damage
Ocean temperatures reached another record high in 2025
Dynamically reconfigurable topological routing in nonlinear photonic systems
Crystallographic engineering enables fast low‑temperature ion transport of TiNb2O7 for cold‑region lithium‑ion batteries
Ultrafast sulfur redox dynamics enabled by a PPy@N‑TiO2 Z‑scheme heterojunction photoelectrode for photo‑assisted lithium–sulfur batteries
Optimized biochar use could cut China’s cropland nitrous oxide emissions by up to half
Neural progesterone receptors link ovulation and sexual receptivity in medaka
A new Japanese study investigates how tariff policies influence long-run economic growth
Mental trauma succeeds 1 in 7 dog related injuries, claims data suggest
Breastfeeding may lower mums’ later life depression/anxiety risks for up to 10 years after pregnancy
Study finds more than a quarter of adults worldwide could benefit from GLP-1 medications for weight loss
[Press-News.org] Houston Janitorial Services Creates World Class Training SystemHouston Janitorial Services Company has saved numerous Houston companies hundreds of thousands of dollars in operations and maintenance costs by making sure its staff are the best-trained in the industry. The Tier One Safety System has a new tool.